德展健康 (000813.SZ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	396.2M	396.8M	466.5M	498.1M	570.9M
Cost of Revenue	188.0M	174.0M	167.3M	205.5M	254.1M
Gross Profit	208.2M	222.8M	299.1M	292.6M	316.7M
Operating Expenses
R&D Expense	89.1M	82.3M	68.4M	51.1M	51.5M
SG&A Expense	—	—	—	—	—
General & Admin Expense	215.7M	222.0M	210.3M	173.6M	152.4M
Selling & Marketing Expense	82.3M	82.2M	85.7M	91.6M	154.1M
Other Expenses	—	—	—	—	—
Total Operating Expenses	390.4M	383.8M	309.2M	262.8M	308.0M
Cost and Expenses	578.4M	557.8M	476.5M	468.3M	562.1M
Operating Income (EBIT)	(434.8M)	(419.3M)	(42.5M)	80.2M	(118.8M)
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	(435.8M)	(420.4M)	(44.1M)	81.8M	(121.1M)
Income Tax Expense	65.9K	1.5M	(1.9M)	27.6M	32.4M
Bottom Line
Net Income	(357.7M)	(345.4M)	(20.4M)	83.3M	(47.0M)
Earnings from Cont. Ops	(435.8M)	(421.9M)	(42.2M)	54.2M	(153.5M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(357.7M)	(345.4M)	(20.4M)	83.3M	(47.0M)
Per Share
Basic EPS	(CN¥0.17)	(CN¥0.16)	(CN¥0.01)	CN¥0.04	(CN¥0.02)
Diluted EPS	(CN¥0.17)	(CN¥0.16)	(CN¥0.01)	CN¥0.04	(CN¥0.02)
Revenue Per Share	CN¥0.19	CN¥0.19	CN¥0.22	CN¥0.23	CN¥0.26
Shares
Basic Shares Outstanding	2.1B	2.1B	2.1B	2.2B	2.2B
Diluted Shares Outstanding	2.1B	2.1B	2.1B	2.2B	2.2B
Profitability Metrics
EBITDA	—	(317.0M)	44.4M	166.8M	(23.0M)
D&A	—	102.3M	86.9M	86.6M	95.8M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026